Dan Victor

BJ’s has outperformed rivals Costco and Walmart since Barron’s picked it in January.

The company’s unique business model and market positioning sets it up for further upside in its shares.

The stock dropped below a key technical support level this week.

Veeva Systems stock can rally by 30% over the next year.

The stock has underperformed with no clear catalyst for a turnaround in sight.

The golden age for biotech innovation continues.

A timely acquisition expands the company’s production and improves profitability.

The ETF is worth owning for exposure to the entire solar value chain.

Brink’s is growing market share at multiple points of the cash economy.

The company has benefited from consumer conditions. Its expansion plans are on pace.

The company is expanding into higher margin and faster growth offerings.

The stock is still worth buying at around 10 times earnings.

The stock plunged after a disappointing revision lower to the company’s full-year growth target. 

Belden has transformed itself to profit from the AI data-center trend but still trades for value.

The selloff is a buying opportunity for the former Barron’s stock pick.

International expansion and surging profitability help make Remitly Global stock a buy.

John Wiley & Sons licenses its content to AI applications, transforming its revenue base.

The stock is down since Barron’s picked it, but there are reasons to expect better days ahead.

Logitech is reimagining its entire lineup of workplace and gaming devices. Its stock can rally 40%.

Cellebrite’s growth outlook and accelerating profitability make for a compelling opportunity.